Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland
Open Access
- 1 November 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (11) , 4136-4143
- https://doi.org/10.1128/aac.48.11.4136-4143.2004
Abstract
Twenty-nine Proteus mirabilis isolates from 17 Polish hospitals were analyzed. The isolates were resistant to a variety of antimicrobials, and their patterns of resistance to β-lactams resembled those of the constitutive class C cephalosporinase (AmpC) producers. Indeed, β-lactamases with a pI of ∼9.0 were found in all of the isolates, and they were subsequently identified as four AmpC-type cephalosporinases, CMY-4, -12, -14, and -15, of which the two last ones were novel enzyme variants. The enzymes were of Citrobacter freundii origin and were closely related to each other, with CMY-4 likely being the evolutionary precursor of the remaining ones. The blaCMY genes were located exclusively in chromosomal DNA, within EcoRI restriction fragments of the same size of ∼10 kb. In the CMY-12- and -15-producing isolates, an additional fragment of ∼4.5 kb hybridized with the blaCMY probe as well, which could have arisen from a duplication event during the evolution of the genes. In all of the isolates, the ISEcp1 mobile element, which most probably is involved in mobilization of the C. freundii ampC gene, was placed at the same distance from the 5′ ends of the blaCMY genes, and sequences located between them were identical in isolates carrying each of the four genes. These data suggested that a single chromosome-to-chromosome transfer of the ampC gene from C. freundii to P. mirabilis could have initiated the spread and evolution of the AmpC-producing P. mirabilis in Poland. The hypothesis seems to be confirmed by pulsed-field gel electrophoresis typing, which revealed several cases of close relatedness between the P. mirabilis isolates from distant centers and showed an overall similarity between the majority of the multiresistant isolates.Keywords
This publication has 54 references indexed in Scilit:
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Insertion Sequence IS Ecp1B Is Involved in Expression and Mobilization of a bla CTX-M β-Lactamase GeneAntimicrobial Agents and Chemotherapy, 2003
- Chromosomal Integration of a Cephalosporinase Gene from Acinetobacter baumannii into Oligella urethralis as a Source of Acquired Resistance to β-LactamsAntimicrobial Agents and Chemotherapy, 2003
- Occurrence of Newer β-Lactamases in Klebsiella pneumoniae Isolates from 24 U.S. HospitalsAntimicrobial Agents and Chemotherapy, 2002
- Emerging Extended-Spectrum β-Lactamases in Proteus mirabilisJournal of Clinical Microbiology, 2002
- Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year PeriodJournal of Clinical Microbiology, 2002
- Prevalence of β-Lactamases among 1,072 Clinical Strains of Proteus mirabilis : a 2-Year Survey in a French HospitalAntimicrobial Agents and Chemotherapy, 2000
- Characterisation of CMY-4, an AmpC-type plasmid-mediated β-lactamase in a Tunisian clinical isolate ofProteus mirabilisFEMS Microbiology Letters, 1998
- Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- A pSC101-derived plasmid which shows no sequence homology to other commonly used cloning vectorsGene, 1984